Robotics and artificial intelligence represent a future of unimaginable ease, productivity, and prosperity.

Half a century on, space is still the final frontier, but it is one that may soon become vastly more accessible thanks to radical reductions in launch costs brought about by SpaceX.

As the cost of lifting mass into orbit declines, enormous new possibilities for the commercialization of space will arise – a phenomenon akin to the radical reduction in transportation costs that drove growth in the 19th century.

One quandary created by improvements in storage is the growing disparity between the amount of data we collect and our ability to meaningfully interpret that data.

This problem afflicts everything from intelligence agencies seeking to combat terrorism to advertisers and content producers seeking appropriate markets and audiences. We are backing companies producing technologies that make tremendous amounts of data comprehensible to users.

Traditional biotechnology investing faces enormous challenges: incomplete data; extremely high capital costs; long lead times before proof of concept.

So we approach the sector carefully, with faith in the immense potential of biotechnology, but focused on companies that pursue those ends quickly through innovative, cost-effective means.

We support companies that view the Internet as the revolutionary technology it is, and that are willing to harness its unique power in truly novel ways.